If the preliminary decision is finalized this spring, it would sharply limit the number of patients who use the expensive drug.
Published: January 11, 2022 at 10:25PM
from NYT Health https://ift.tt/3HZ21Wq
If the preliminary decision is finalized this spring, it would sharply limit the number of patients who use the expensive drug.
Published: January 11, 2022 at 10:25PM
from NYT Health https://ift.tt/3HZ21Wq
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)